TRIM44, a Novel Prognostic Marker, Supports the Survival of Proteasome-Resistant Multiple Myeloma Cells

Authors

Trung Vu
Yuqin Wang
Annaliese Fowler
Anton Simieou
Nami McCarty

Publication Date

8-26-2024

Journal

Cells

Abstract

TRIM44, a tripartite motif (TRIM) family member, is pivotal in linking the ubiquitin-proteasome system (UPS) to autophagy in multiple myeloma (MM). However, its prognostic impact and therapeutic potential remain underexplored. Here, we report that TRIM44 overexpression is associated with poor prognosis in a Multiple Myeloma Research Foundation (MMRF) cohort of 858 patients, persisting across primary and recurrent MM cases. TRIM44 expression notably increases in advanced MM stages, indicating its potential role in disease progression. Single-cell RNA sequencing across MM stages showed significant TRIM44 upregulation in smoldering MM (SMM) and MM compared to normal bone marrow, especially in patients with t(4;14) cytogenetic abnormalities. This analysis further identified high TRIM44 expression as predictive of lower responsiveness to proteasome inhibitor (PI) treatments, underscoring its critical function in the unfolded protein response (UPR) in TRIM44-high MM cells. Our findings also demonstrate that TRIM44 facilitates SQSTM1 oligomerization under oxidative stress, essential for its phosphorylation and subsequent autophagic degradation. This process supports the survival of PI-resistant MM cells by activating the NRF2 pathway, which is crucial for oxidative stress response and, potentially, other chemotherapy-induced stressors. Additionally, TRIM44 counters the TRIM21-mediated suppression of the antioxidant response, enhancing MM cell survival under oxidative stress. Collectively, our discoveries highlight TRIM44's significant role in MM progression and resistance to therapy, suggesting its potential value as a therapeutic target.

Keywords

Multiple Myeloma, Humans, Tripartite Motif Proteins, Prognosis, Cell Line, Tumor, Proteasome Endopeptidase Complex, Biomarkers, Tumor, Autophagy, Cell Survival, Intracellular Signaling Peptides and Proteins, Proteasome Inhibitors, Drug Resistance, Neoplasm, Sequestosome-1 Protein, NF-E2-Related Factor 2, Gene Expression Regulation, Neoplastic

Comments

Supplementary Materials

Data Availability Statement

PMID: 39273003